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Within a cell, the levels and activity of multiple pro- and anti-apoptotic molecules 
act in concert to regulate commitment to apoptosis. Whilst the balance between 
survival and death can be tipped by the effects of single molecules, cellular 
apoptosis control pathways very often incorporate key transcription factors that 
co-ordinately regulate the expression of multiple apoptosis control genes. C-
terminal binding proteins (CtBPs), which were originally identified through their 
binding to the Adenovirus E1A oncoprotein, have been described as such 
transcriptional regulators of the apoptosis program. Specifically, CtBPs function 
as transcriptional co-repressors, and have been demonstrated to promote cell 
survival by suppressing the expression of several pro-apoptotic genes. In this 
review we summarise the evidence supporting a key role for CtBP proteins in cell 
survival. We also describe the known mechanisms of transcriptional control by 
CtBPs, and review the multiplicity of intracellular signaling and transcriptional 
control pathways with which they are known to be involved. Finally we consider 
these findings in the context of additional known roles of CtBP molecules, and 
the potential implications that this combined knowledge may have for our 
comprehension of diseases of cell survival, notably cancer. 
 
Keywords: CtBP, apoptosis, transcriptional repression, Golgi, cancer. 
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Discovery of CtBPs: cellular binding partners of transforming 
viral oncoproteins 
 
Isolation of the cellular binding partners of the viral transforming oncoproteins has, historically, 
proven to be a fruitful approach for the identification of key cellular regulators of proliferation 
and survival. E1A proteins of type 2/5 adenoviruses, in particular, associate with multiple 
cellular proteins in order to reprogram cellular growth, survival and differentiation pathways to 
facilitate viral gene expression and replication.1,2 E1A proteins are encoded by two exons; the 
first exon, which contains conserved regions that bind to the cellular proteins Rb and p300/CBP, 
is sufficient for E1A to co-operate with activated ras in baby rat kidney (BRK) cell co-
transformation assays.3,4 E1A truncation mutants lacking exon 2 are markedly more effective 
than wild type E1A in these assays, although intriguingly, the loss of these C-terminal sequences 
renders E1A unable to cooperate with Adenovirus E1B in transformation assays, or immortalize 
BRK cells in the absence of a co-operating oncogene.3,5-7  
 
The region in exon 2 that conferred these effects was subsequently mapped to a 14 amino acid 
sequence in the C-terminus of the protein. CtBPs were identified as the cellular proteins that 
interact with a PxDLS peptide consensus within this sequence.8-10 Further viral oncoproteins, 
EBNA3A and EBNA3C, also contain variants of this sequence and bind CtBPs, and EBNA3C 
requires CtBP-binding for co-transformation with mutant ras.11,12 Reports identifying the 
presence of a functional CtBP-binding consensus sequence in the Drosophila transcriptional 
repressors, Hairy, Knirps and Snail,13-15 were the first of many that have defined a normal 
cellular function of CtBPs as transcriptional co-repressors of DNA-binding transcription 
factors.16,17 
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CtBP structure and function 
 
Gene and protein structure 
 
In Drosophila there is a single dCtbp gene, whereas humans and mice have two CtBP-encoding 
genes, Ctbp1 and Ctbp2. In humans these map to chromosomes 4p16 and 10q26.13 respectively, 
the chromosomal location that was initially assigned.to CtBP210 having been one of a number of 
Ctbp pseudogenes. Transcripts from both Ctbp1 and Ctbp2 are widely expressed in both adult 
tissue, and during development.10,18-20 Ctbp1 is expressed in a greater number of tissues and often 
at greater levels than Ctbp2.18,20 Interestingly, Ctbp2 expression patterns differ between human 
and mouse.10 In retinal cells, use of an alternative, tissue-specific promoter in the first intron of 
the Ctbp2 gene leads to the production of mRNA encoding the synaptic ribbon protein RIBEYE, 
which consists of a large, unique N-terminal domain fused to all but the N-terminal 20 amino 
acids of CtBP2.21,22 Similarly, the protein originally identified as CtBP3/BARS in the rat,23 and 
which is also expressed in human cells,24 lacks the first 13 a.a. of CtBP1 and almost certainly 
represents an alternatively spliced transcript of the Ctbp1 gene. For the purposes of this review, 
functions so far ascribed solely to CtBP3/BARS will be considered as potential characteristics of 
all CtBP proteins, whilst the specialised role of RIBEYE will not be discussed further.  
 
The proteins encoded by Ctbp1 and Ctbp2 share 78% amino acid identity and 83% similarity.10 
They appear to function interchangeably, although evidence is emerging from analysis of mouse 
models and various post-translational modifications that their activity is differentially 
regulated.19,25 CtBPs are characterized by a significant degree of homology between their central 
domain and NAD+-dependent dehydrogenase enzymes (Figure 1). However, whilst CtBPs 
possess weak in vitro dehydrogenase activity, the significance of this remains unclear.26,27 This 
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domain does however have an important role as a dimerization site, allowing the formation of 
homo- and hetero-dimers between CtBP1 and CtBP2.20,26,28 Critically, dimerization is stimulated 
by the occupation of a dinucleotide-binding site within the domain,26,27,29 the preferred ligand of 
which being NADH, which binds to the site with >100 fold higher affinity than NAD+.30,31  
 
The three-dimensional structure of CtBPs comprises a single globular domain formed by its N- 
and C-terminal regions, linked to the core dimerization domain through two flexible hinges.26,28 
Within this globular domain, the CtBP N-terminus contains a PxDLS peptide binding cleft, and 
the C-terminus has been proposed to play a regulatory role.28,32 Notably, the conformational 
changes induced upon NADH binding are propagated to the N-terminus, and promote binding to 
E1A and other PxDLS containing proteins.26,28 Importantly, a CtBP dimer has the potential to 
form the core of a complex containing two PxDLS-containing proteins. 
 
CtBP functions in the nucleus and cytoplasm 
 
Two distinct functions have been assigned to CtBP proteins – a nuclear role in the regulation of 
transcription, and a distinct function, thus far only directly ascribed to the CtBP3/BARS isoform, 
in regulating Golgi membrane maintenance. The role in transcription was first indicated by 
studies on E1A that showed when exon 1 of E1A is fused to a sequence-specific DNA-binding 
domain it activated transcription, and this activation is inhibited by the presence, in cis, of the 
CtBP-binding region of exon 2.33 Subsequent fusion of CtBP itself to a DNA-binding domain 
provided direct evidence that CtBPs repress transcription.15,34,35 A large number of DNA-binding 
transcriptional repressors have now been shown to recruit CtBPs, the majority, but not all,36 
containing a consensus PxDLS sequence16,17,37. The best characterized of these are the Snail, 
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Slug, and ZEB/δEF1 factors, which together recruit CtBPs to repress the expression of epithelial-
specific genes in mesenchymal cells.13,18,38-42 These, and other CtBP-recruiting factors with 
potential roles in the control of apoptosis, are discussed in more detail in subsequent sections. 
 
CtBPs employ a number of mechanisms to regulate gene transcription, as summarized in Figure 
2. The most extensively characterized mechanism whereby it acts as a transcriptional co-
repressor is by the recruitment of a co-repressor complex, which includes class I histone 
deacetylases (HDACs) and histone methyltransferases (HMTs), and resulting in the co-ordinated 
modification of chromatin into a repressed state.43 CtBPs can also recruit class II HDACs,44 as 
well as repress transcription without HDAC involvement.35,45 An additional mechanism whereby 
CtBPs appear to act as a co-repressor is by promoting the recruitment of Polycomb proteins to 
DNA.20,46 These repress transcription through several mechanisms, including by compacting 
chromatin.47 Finally, recent research has also determined that CtBPs interact with histone 
acetyltransferase (HAT) co-activators such as p300, CBP and pCAF and prevents their 
interaction with chromatin.48  
 
Independently of its role in regulating transcription, CtBP (in the form of CtBP3/BARS) was 
cloned as a protein involved in the disassembly of the Golgi complex.23 CtBP3/BARS is able to 
induce the breakdown of tubular Golgi networks.49 It is responsible for driving the fission of 
Golgi membranes during mitosis and also plays a role in endocytic and exocytic pathways.50-52 
The distinct nuclear and cytoplasmic functions of CtBPs may be defined by the conformational 
shift induced by occupation of the dinucleotide binding site, with NADH driving CtBPs towards 
a nuclear function, and acyl-CoA, which also binds CtBPs, promoting the monomeric, 
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cytoplasmic form.28,52 Ultimately, it will require the use of specific CtBP mutants to dissect the 
relative contributions of these distinct functions of CtBPs in cell proliferation and survival. 
 
CtBP functional knockouts reveal key roles for CtBPs in 
differentiation, cell cycle progression and the suppression of 
apoptosis 
 
Before considering the multiplicity of signaling pathways and transcription control networks that 
CtBPs are involved in, it is useful to review the effects of experimentally abrogating CtBP 
expression or function on the phenotype of the organism or the individual cell. Homozygous 
inactivation of the dCtbp gene in Drosophila is lethal, with embryos displaying severe defects in 
segmentation, consistent with a role for dCtBP in the function of Hairy, Knirps and Snail 
transcriptional repressors.13-15 In Xenopus embryos, injection of mRNA encoding an xCtBP 
fusion protein designed to activate, rather than repress, transcription, resulted in similarly 
dramatic defects such as loss of head and/or eyes and a shortened anterior-posterior axis.53 In 
murine development, homozygous deletion of Ctbp1 results in mice which develop normally, but 
are smaller than heterozygotes.19 Ctbp2-/-embryos exhibited multiple defects, including axial 
truncations and abnormal heart and brain development, and embryonic lethality occurred due to 
defects in extra-embryonic vascularization. Crosses between Ctbp1+/- and Ctbp2+/- revealed 
further developmental defects, with Ctbp1-/-/Ctbp2-/- embryos showing the most severe 
phenotype.  
 
Murine embryonic fibroblasts (MEFs) from Ctbp1-/-/Ctbp2-/- embryos have been established, and 
immortalised with SV40 large T antigen. They have defects in CtBP-sensitive gene transcription, 
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but normal Golgi apparatus.19 They are, however, hypersensitive to apoptosis in response to 
diverse stimuli including loss of cell-cell contact (anoikis), genotoxic chemotherapeutics, 
staurosporine, and Fas ligand.54 Validated micro-array analysis showed two classes of genes to 
be constitutively up-regulated in these Ctbp null cells, and suppressed, by CtBP1 re-expression: 
those encoding epithelial-specific proteins including E-cadherin and several keratins, and pro-
apoptotic proteins including PERP, PTEN, insulin-like growth factor binding proteins, Bax, 
Noxa and Id-1.54 Together with separate evidence that siRNA-mediated CtBP ‘knockdown’ in 
human tumor cell lines is sufficient to induce apoptosis in the absence of any additional stress,55 
these data confirm previous indirect evidence from studies on E1A,39 that CtBPs function as 
global repressors of the pro-apoptotic program.  
 
The above studies attributed the effects of CtBP ablation on cellular phenotype to the 
transcriptional function of CtBPs. Interestingly, another group has independently knocked down 
CtBP expression in rat cell lines. Rather than apoptosis, they observed G2 arrest, which they 
demonstrated to be consistent with the disruption of Golgi architecture.50,52 Further clarification 
is undoubtedly warranted. 
 
CtBP regulates multiple transcription factor networks with 
roles in tumorigenesis and survival 
 
Whilst the precise mechanisms that link CtBPs to the suppression of pro-apoptotic gene 
expression programs remain essentially undefined, molecular studies have identified physical 
and functional involvement of CtBPs with numerous cellular transcription factors. Some of these 
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interactions that are likely to have particular relevance to cell survival pathways and 
tumorigenesis are reviewed in the following sections and summarized in Figure 3. 
 
Repression of the epithelial phenotype 
Negative regulation of the expression of epithelial-specific genes, and particularly those 
encoding E-cadherin, desmoglein-2, plakoglobin and various keratins, is perhaps the most well-
characterized function of CtBP proteins. E-cadherin is a calcium-dependent membrane protein 
required for the formation of adherens junctions, which are essential for cell adhesion and 
intercellular interactions56. It interacts with the actin cytoskeleton via catenins to mediate cellular 
integrity, polarity and morphogenesis.41,57,58 Loss of E-cadherin expression in epithelial cells is 
associated with an event referred to as epithelial-mesenchymal transformation (EMT). EMT is a 
major mechanism of vertebrate embryological tissue remodeling, which involves a switch in 
expression of epithelial- to mesenchymal cell specific genes, resulting in a characteristic motile, 
migratory mesenchymal phenotype.59 EMT and loss of E-cadherin expression is also associated 
with disease progression, increased malignancy and poor prognosis in many epithelial tumors, 
including those of the colon, stomach, lung, bladder, oesophagus, prostate and breast.60-66 Along 
with increased invasive properties, one of the key outcomes of EMT is a marked reduction in a 
cell’s susceptibility to pro-apototic stimuli such as loss of cell-cell contact, growth factor 
withdrawal, and TNF-α.39,67 
 
Activation of transcription from the E-cadherin promoter is driven by ubiquitously expressed, 
and constitutively active transcription factors. Its lack of expression in cells of mesenchymal 
origin is due primarily to the interaction of Snail, Slug and ZEB/δEF1 transcriptional repressors 
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to E-box elements within their promoters.41,68 These repressors all contain PxDLS motifs which 
are required, at least in part, for their repressor activity.15,18,42,69 Their expression and activity is 
regulated throughout development, and is important during carcinogenesis. Snail expression, for 
example, is predictive of poor prognosis in breast and hepatocellular carcinoma.70-73 CtBPs can 
associate with the E-cadherin promoter in cells with a non-epithelial phenotype,43 and down-
regulation of CtBP activity, either by the C-terminus of E1A, or Ctbp gene disruption, results in 
changes in histone modifications at the E-cadherin promoter, and de-repression of E-cadherin 
transcription.39,43,54 Interestingly, the protein pinin/DRS, which is known to promote the 
epithelial phenotype, binds CtBPs and relieves its repression of the E-cadherin promoter.74 
 
One model that has been proposed, but not yet experimentally tested, is that the repression of 
pro-apoptotic genes by CtBPs may be an indirect consequence of EMT. Another factor to 
consider is the recruitment of CtBPs by Snail, Slug or ZEB/δEF1 to the promoters of other 
genes, such as BRCA2.42 It will be of interest to establish whether CtBPs directly associate with 
the promoters of pro-apoptotic genes, as well as determining the effects of inhibiting CtBP 




Some of the developemental defects observed following loss of CtBP function are suggestive of 
defects in the Wnt signaling pathway.53 Binding of Wnt to its cell surface receptors results in the 
accumulation of free cytoplasmic β-catenin followed by its translocation to the nucleus, where it 
acts as a co-activator for TCF family transcription factors.75 Constitutive activation of this 
pathway occurs in multiple human cancers, notably colorectal carcinoma where it is associated 
Page 10 of 34 10
Bergman & Blaydes         CtBP proteins 
with suppression of apoptosis.76 In Xenopus, xCtBP was found to bind, and act as a co-repressor 
for xTCF-3, which functions as a transcriptional repressor in the absence of Wnt pathway 
activation.53 In mammalian cells, CtBPs do not interact with TCFs, but rather bind the product of 
the Adenomatous polyposis coli (APC) gene.77 This results in CtBP-mediated suppression of Wnt 
signaling by sequestering complexes of APC and β-catenin away from TCF transcription factors. 
In this context, therefore, CtBPs actually appear to play a role in promoting apoptosis and tumor 
suppression. 
 
Transforming Growth Factor- β (TGF-β) signaling pathways 
A common chromosomal translocation of a number of myeloid malignancies, including acute 
myeloid leukaemia, chronic myelogenous leukemia and myelodysplastic syndromes, results in 
the production of a fusion protein with AML1 and Evi-1, driven by the AML1 promoter.78 Under 
normal conditions, Evi-1 is barely detectable in bone marrow and peripheral blood; however 
over-expression of AML1/Evi-1 is associated with transformation of haematopoietic stem cells. 
Evi-1 is a transcriptional repressor, and a negative regulator of (TGF-ß) signaling. Evi-1 acts on 
TGF-ß-mediated regulation of cellular proliferation and differentiation by repressing the TGF-β 
activated transcription factor, Smad3. Effective inhibition of TGF-β signaling and promotion of 
cellular transformation by both AML1/Evi-1 and Evi-1, is dependent upon their recruitment of 
CtBPs, through a PxDLS motif.78-82 
 
TGF-β has a complex role in regulating apoptotic pathways, and can activate either pro- or anti-
apoptotic pathways, depending on cell type.83 Whilst the interaction with Evi-1 is consistent with 
an anti-apoptotic role for CtBPs,84 CtBPs also interact with several other key components of 
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TGF-β signaling pathways that may also control cell survival. TGIF interacts with a TGF-β 
activated Smad complex to repress Smad-mediated transcription, this repression involves the 
recruitment of CtBPs by a PxDLS motif in TGIF.85 The importance of the TGIF-CtBP 
interaction in human development is demonstrated by an inherited point mutation in the PxDLS 
motif in TGIF, which results in defects in craniofacial development.85 CtBPs also interact with 
the inhibitory Smad, Smad6, which contributes to the repression of Id-1 gene transcription.86 Id-1 
is up-regulated in Ctbp1-/-Ctbp2-/- MEFs,54 and can either induce or suppress apoptosis, 
depending on the cellular context.87,88 CtBPs are also recruited to Smads indirectly through 
ZEB/δEF1 proteins, particularly ZEB-2, repressing TGB-β induced transcription.89 
 
Growth factor receptor, and nuclear hormone receptor signaling 
Ets protein family members are key transcriptional activating factors that transmit signals from 
growth factor-induced ras-signaling pathways to changes in gene expression, for example 
through their binding to the serum response element (SRE) on the c-fos promoter. Net is a 
somewhat atypical Ets family member in that, under certain conditions, it can also function as a 
transcriptional repressor. Criqui-Filipe et al 32 demonstrated that Net contains a CtBP binding 
site, and in the absence of serum growth factors it recruits CtBPs to actively repress transcription 
from  SRE-dependent promoters. 
 
Ligand-activated nuclear hormone receptors play a key role in regulating cell proliferation, 
differentiation, and survival in diverse tissue types. Typically, ligand binding to its receptor 
results in the recruitment of transcriptional co-activators to induce target gene expression. 
RIP140 is unusual in this respect, as it is recruited to most activated nuclear hormone receptors, 
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but acts as a transcriptional repressor. It appears to be essential for suppressing nuclear hormone 
receptor-induced transcription in certain tissues, to allow key processes such as ovulation and 
adipogenesis.90 Recruitment of CtBPs by RIP140, which is regulated by acetylation of a lysine 
residue adjacent to the PxDLS sequence on RIP140,36 plays an important role in the repressor 
activity of RIP140.36,91 
 
C-terminal binding protein interacting protein (CtIP) 
CtIP was originally identified as a PxDLS-containing binding partner for CtBP.92 It is a large, 
125 kDa nuclear protein that plays a complex role in transcriptional repression, cell cycle control 
and DNA damage responses. CtIP acts as a molecular bridge to recruit CtBPs to at least two 
known transcriptional repressors: the G1 checkpoint regulator, Rb,45 and the haemo-lymphoid 
factor, Ikaros.93 In both cases, the CtBP-CtIP complex is thought to co-operate with these factors 
to co-repress target gene transcription. Mice with heterozygous inactivation of the Ctip gene 
show increased incidence of multiple tumor types, particularly large lymphomas. This is 
consistent with a tumor suppressor role for the protein, although the wild-type Ctip allele is not 
lost in the cancers.94 However, homozygous Ctip gene inactivation results in lethality very early 
in mouse embryogenesis, with cells arresting prior to S phase, and also showing elevated levels 
of cell death. Experiments on cell lines showed this G1 arrest to be Rb-dependent, and associated 
with elevated levels of the cyclin dependent kinase inhibitor, p21WAF1.94  
 
Potentially some of these effects of CtIP loss may be accounted for by its interaction with the 
BRCT domains of the BRCA1 protein.95,96 BRCA1 is a well characterized tumor-suppressor 
protein that plays a central role in DNA damage response.97,98 It has been reported that BRCA1 
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recruits the CtIP-CtBP complex to repress transcription of BRCA1 target genes such as gadd45 
and WAF-1, and that this association is disrupted following DNA damage,99,100 although some of 
these findings have subsequently been disputed.101,102 BRCA1–CtIP complex formation is 
critical for the DNA damage-induced G2/M checkpoint, though the role of CtBPs in this is 
undetermined.103 
 
Regulation of p53-dependent pro-apoptotic genes 
P53 is a stress-activated transcription factor that plays a central role in the regulation of cell 
proliferation, and the induction of apoptosis.104 Many of the genes up-regulated in Ctbp1-/-Ctbp2-
/- MEFs are known transcriptional targets of the pro-apoptotic transcription factor p53, however 
CtBPs could repress their transcription independently of p53 function.54 It seems likely that one 
consequence of repression of a distinct subset of p53-target genes by CtBPs would be to either 
dampen, or otherwise modify the cellular response to p53 activation. 
 
CtBPs also directly suppress p53-dependent transcription through its interaction with the Hdm2 
oncoprotein.105 Hdm2 is the major cellular regulator of p53 protein function, inhibiting the 
interaction of p53 with transcriptional co-activators, and driving its export from the cytoplasm 
and degradation by the proteosome.106 Hdm2 also recruits CtBPs to p53, repressing p53-
dependent promoters such as bax.105 This provides an additional mechanism whereby CtBPs 
suppress apoptosis in cells that retain a functional p53 stress-response pathway. 
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Regulation of CtBP function by stress and survival signaling 
pathways 
 
In addition to interacting with the known components of signaling pathways described above, it 
is becoming clear that the activity of CtBPs themselves are regulated by post-translational 
modification and protein-protein interactions in response to a range of intracellular signals. In 
some cases, the associated changes in CtBP activity have a direct effect on cell survival.  
 
Before the Ctbp genes were even cloned, their protein products were known to be 
phosphorylated in a cell-cycle dependent manner,8 however the enzymes responsible, and the 
effect on CtBP function has yet to be clarified. Phosphorylation of CtBP does, however, play a 
key role in the induction of apoptosis in response to UV-irradiation activated stress-signaling. 
High doses of UV activate homoedomain interacting protein kinase 2 (HIPK2), an enzyme which 
has a known role in pro-apoptotic signaling through its phosphorylation and activation of p53.107-
109 HIPK2 phosphorylates CtBP1 at serine 422 (the site is conserved in CtBP2), which results in 
the targeting of CtBP1 for ubiquitin-dependent degradation by the proteosome.55,110 The 
subsequent decrease in CtBP protein levels is sufficient to trigger apoptosis in p53 null cells, and 
either siRNA ‘knockdown’ of HIPK2, or over-expression of a serine 422 mutant of CtBP1 
incapable of being phosphorylated, inhibits UV-induced apoptosis. 
 
CtBPs are also regulated at the level of their subcellular distribution, with nuclear localization 
being required for transcriptional repressor activity. In most cell types examined, CtBP1 and 
CtBP2 are predominantly detectable in the nucleus. To some extent, this nuclear localization is a 
consequence of recruitment by PxDLS-containing transcription factors such as Net.32 CtBP1 is 
also regulated at this level through two mutually exclusive modifications. SUMOylation at lysine 
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428 following interaction with the SUMO E3 ligases Pc2, PIAS1, or PIASxβ promotes nuclear 
localization of CtBP1, whereas interactions of its C-terminal PDZ domain with neuronal nitric 
oxide synthase (nNOS), and potentially other proteins, promotes cytoplasmic 
localization.25,111,112 It is not yet clear whether CtBP2 localization and activity is similarly 
regulated, as the critical SUMOylation consensus site is not conserved, even though CtBP2 is 
also SUMOylated by Pc2.112 Regulation of these interactions in response to cellular signaling has 
yet to be established. Signaling pathways downstream of growth factor tyrosine kinase receptors 
do, however, regulate CtBP subcellular localization. The kinase Pak1, which is activated by 
multiple growth factors including Heregulin and epidermal growth factor, phosphorylates CtBP1 
at serine 158. This results in a transient exclusion of CtBP1 from the nucleus following growth 
factor stimulation.113 This serine is conserved in CtBP2, but it is not yet known whether CtBP2 is 
similarly regulated. This effect is intriguing, given that these factors are associated with cell 
survival, rather than the induction of apoptosis, and suggest that transient exclusion of CtBPs 
from the nucleus may be required for certain responses to growth factor stimulation, and does 
not, in itself, induce apoptosis. 
 
Probably the most interesting mechanism of regulation of CtBPs is the conformational change 
induced by occupancy of the dinucleotide binding site. NADH binding to CtBPs promotes both 
its dimerization and interaction with PxDLS-containing transcriptional repressors, and 
consequently promotes its ability to repress transcription from a set of target promoters.29,31,44 
Conversely, the NADH unbound form preferentially binds to Hdm2, which represses p53-
dependent transcription,105 and also to p300/CBP, with potentially broad ranging effects on 
p300-dependent gene transcription.48 Levels of intracellular NADH show dramatic changes at 
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birth, in response to ethanol, cellular hypoxia, and in metabolic disease such as diabetes. 
Potentially, CtBPs may regulate broad-ranging changes in gene expression patterns in response 
to these alterations in cellular metabolism. 
 
Future perspectives 
CtBPs are clearly involved in numerous transcriptional regulatory programs and intracellular 
signaling pathways that regulate cell proliferation, differentiation and survival. Given that loss of 
CtBP expression induces either apoptosis or G2 arrest, one might predict that cellular levels of 
CtBPs might be elevated in diseases of dysregulated proliferation and survival, such as cancer. 
However the pleiotrophic nature of CtBPs activities may complicate its role in carcinogenesis. 
Indeed, in one of the few published studies of CtBP protein expression in human primary 
cancers, CtBP1 levels were markedly reduced in malignant melanomas, compared to primary 
melanocytes.114 This was found to be consistent with a role for CtBPs in suppressing the 
expression of MIA, a protein associated with malignant progression in this tumor type,114,115 and 
highlights the need for further studies into CtBP expression patterns in other tumor types. 
 
In contrast, microarray analysis of follicular thyroid carcinomas found a mean 3.6 fold increase 
in Ctbp2 mRNA levels in a defined subset of these tumors.116 Unfortunately, the commercial 
qPCR assay used to validate these findings recognises the unique exon 1 found in the ribeye 
transcript, and therefore the role of CtBP2 in these tumors remains to be confirmed. CtBPs are, 
however, ubiquitously expressed, and are detectable in the majority of cancer cell lines that have 
been examined. The finding that cells derived from Ctbp1-/-Ctbp2-/- embryos proliferate 
normally, whereas siRNA-mediated knockdown of CtBPs in cancer cell lines can induce 
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apoptosis, could have a number of explanations, one of which is that some of genetic changes 
associated with cellular transformation render cells more dependent on the suppression of pro-
apoptotic genes by CtBPs. This would be entirely consistent with the original observations that 
full length E1A is required for cellular immortalization, whereas exon 2, which functions at least 
in part by preventing the interaction of CtBPs with cellular PxDLS containing transcription 
factors,117 suppresses transformation in the presence of mutant ras.  
 
In summary, CtBPs are clearly key regulators of both gene transcription and organelle assembly. 
They have been implicated in the context of a striking number of transcriptional regulatory 
networks, and intracellular signaling pathways. They play an essential pro-survival role in 
tumour-derived cells, though, intriguingly the mechanism basis of this critical function remains 
to be clarified. Further studies will undoubtedly shed light on these multifaceted molecules.  
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